Biological membrane fusion is dependent on protein catalysts to mediate localized restructuring of lipid bilayers. A central theme in current models of protein-mediated membrane fusion involves the sequential refolding of complex homomeric or heteromeric protein fusion machines. The structural features of a new family of fusionassociated small transmembrane (FAST) proteins appear incompatible with existing models of membrane fusion protein function. While the FAST proteins function to induce efficient cell-cell fusion when expressed in transfected cells, it was unclear whether they function on their own to mediate membrane fusion or are dependent on cellular protein cofactors. Using proteoliposomes containing the purified p14 FAST protein of reptilian reovirus, we now show via liposome-cell and liposome-liposome fusion assays that p14 is both necessary and sufficient for membrane fusion. Stoichiometric and kinetic analyses suggest that the relative efficiency of p14-mediated membrane fusion rivals that of the more complex cellular and viral fusion proteins, making the FAST proteins the simplest known membrane fusion machines.
Introduction
Biological membrane fusion requires protein catalysts to overcome the thermodynamic barriers that prevent spontaneous merger of membranes. Studies of viral and cellular fusion proteins have provided detailed structural and functional insights into the protein complexes that mediate membrane merger (Skehel and Wiley, 2000; Ungar and Hughson, 2003) . In the case of enveloped viruses, the fusion catalyst is provided by multimeric glycoproteins that exist as metastable structures embedded in the virus envelope (Earp et al, 2005) . Following structural rearrangements, a previously sequestered hydrophobic fusion peptide motif is extended toward, and inserts into, the target cell membrane, anchoring the viral fusion protein in both membranes (Tamm et al, 2002) . In contrast, intracellular fusion of transport vesicles is dependent on the pairing of a preformed vesicle (v)-SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor) complex with a cognate target membrane (t)-SNARE to form a trans-acting heteromeric complex (Ungar and Hughson, 2003) . In spite of extensive structural diversity in these fusion protein complexes, there are striking similarities in the structural rearrangements that accompany the fusion reaction (Skehel and Wiley, 1998; Weber et al, 1998) . However, a clear understanding of the energetics and lipid rearrangements involved in protein-mediated membrane fusion remains incomplete.
A new family of viral proteins involved in cell-cell membrane fusion has recently been described, whose features are incongruent with existing models of protein-mediated membrane fusion. The fusion-associated small transmembrane (FAST) proteins are encoded by the fusogenic reoviruses, an unusual group of nonenveloped viruses that induce syncytium formation . The FAST protein family is comprised of the p10 proteins of avian reovirus and Nelson Bay reovirus, the p14 protein of reptilian reovirus, and the p15 protein of baboon reovirus (Shmulevitz and Duncan, 2000; Dawe and Duncan, 2002; . Unlike enveloped virus fusion proteins, the FAST proteins are nonstructural viral proteins and are not involved in virus entry. The sole defined function of the FAST proteins is the induction of cell-cell fusion following their expression in reovirus-infected cells and trafficking through the ER-Golgi pathway to the plasma membrane (Shmulevitz et al, 2004a) .
Structural and functional properties of the FAST proteins distinguish them from both enveloped virus fusion proteins and SNARE proteins, although they share certain features with each of these distinct groups of membrane fusion proteins. The FAST proteins assume a bitopic N exoplasmic / C cytoplasmic (N exo /C cyt ) membrane topology with small, approximately equal-sized ecto-and endodomains (Shmulevitz and Duncan, 2000; Dawe et al, 2005) . At 95-140 residues in size, the FAST proteins are more similar in size to SNARE proteins than enveloped virus fusion proteins. They also function, in effect, as 'cellular' fusion proteins mediating cell-cell rather than virus-cell membrane fusion. However, the FAST proteins lack the heptad repeat sequences responsible for formation of the helical bundles characteristic of the SNARE proteins and of the class I enveloped virus fusion proteins (Skehel and Wiley, 1998) . Similarly, the p10 and p14 FAST proteins contain short regions (18-20 residues) of moderate hydrophobicity in their ectodomains that may function in an analogous manner as the enveloped virus fusion peptide or fusion-loop motifs, serving to destabilize lipid bilayers Gibbons et al, 2004; Modis et al, 2004) . However, the fusion peptide motifs of the p10 and p14 FAST proteins are considerably less hydrophobic than typical fusion peptides, they comprise approximately half of the ectodomains of these proteins, and the p14 fusion peptide motif has an obligate requirement for myristoylation Shmulevitz et al, 2004b) . The unusual structural features of the FAST proteins are difficult to reconcile with existing models of protein-mediated membrane fusion, all of which invoke significant energy input derived from extensive rearrangement of homo-or heteromeric complexes (Kozlov and Chernomordik, 1998; Bentz, 2000; Bentz and Mittal, 2003) .
Expression of individual FAST proteins in transfected cells induces efficient syncytium formation in different cell types. In addition, numerous point mutations eliminate cell-cell fusion activity without altering FAST protein topology or trafficking, clearly indicating that the FAST proteins are intimately involved in the membrane fusion reaction and are the only reovirus proteins required for syncytium formation (Shmulevitz and Duncan, 2000; Shmulevitz et al, 2003; . The remarkable physical attributes of the FAST protein family, however, questioned whether the FAST proteins are membrane fusion proteins per se and can function by themselves to induce membrane fusion, or whether they function through unidentified cellular fusion factors that serve as the actual membrane fusion complex. Using proteoliposomes containing the purified p14 FAST protein, we now show that p14 is both necessary and sufficient for membrane fusion, and that the activity of this minimal protein-mediated membrane fusion machine rivals that of the more complex viral and cellular fusion complexes.
Results

p14 does not form homomeric trans-acting complexes
The p14 FAST protein of reptilian reovirus (Figure 1 ) has an B36-residue ectodomain containing an N-terminal myristate moiety and a 20-residue moderately hydrophobic patch that includes a loop structure (residues 5-13). Both the myristate moiety and the hydrophobic patch are essential for p14 membrane fusion activity . The 68-residue endodomain contains a membrane-proximal polybasic region (nine residues of 18 in this region are basic) of no known function and a nonessential C-proximal polyproline motif. To determine whether p14 must be present in both membranes undergoing fusion, p14-transfected cells were monitored for fusion to nontransfected target cells using a fluorescent heterotypic cell-cell fusion assay. As indicated by the presence of numerous large syncytia, all of which contained both donor (red) and target (blue) cell nuclei ( Supplementary Figure 1) , p14 does not need to form trans-acting homomeric complexes to effect membrane fusion.
Reconstitution of p14-proteoliposomes
Baculovirus-expressed p14 was purified to near homogeneity in the presence of n-octyl b-D-glucopyranoside (OG) (Supplementary Figure 2) . The purified protein was reconstituted into large (400 nm diameter) unilamellar vesicles (LUVs) by mixing detergent-suspended p14 with LUVs presaturated with detergent, followed by removal of the detergent. Sucrose gradient fractionation and SDS-PAGE analyses of the resulting protein-lipid mixtures revealed inefficient incorporation of p14 into liposomes when the detergent was removed by dialysis at 41C or room temperature ( Figure 2B , lanes 1-6), as evidenced by the presence of p14 in the protein-lipid aggregate (20-30% sucrose) and free protein (30% sucrose) fractions of the gradient. However, stepwise dilutions at 41C, but not at room temperature, to gradually lower the OG concentration in 0.1% increments resulted in efficient incorporation of p14 into liposomes ( Figure 2B , lanes 7-9 versus 10-12). Apparently, the rate of detergent depletion and temperature influences on membrane fluidity, protein-detergent, and/or lipid-detergent interactions influence the efficiency of p14 incorporation into proteoliposomes.
Electron microscopy confirmed that the p14-liposomes consisted of LUVs ( Figure 2C ). Immunofluorescent staining of the p14-liposomes, using antisera specific for the N-terminal ectodomain or for the C-terminal enterokinase tag, revealed that a significant proportion of p14 resides in the correct N out /C in topology ( Figure 2D ). The low level of staining observed with the anti-enterokinase antibody was consistently above background levels, suggesting that at least a proportion of p14 may reside in the inverse N in /C out topology, as previously reported for other membrane proteins inserted into detergent-saturated liposomes (Rigaud and Levy, 2003) . Calculations based on quantitative analysis of phospholipid and protein concentrations in the isolated proteoliposomes estimated an average protein:lipid molar ratio of B1:300 (i.e. 3-3.5 p14 molecules per thousand lipid molecules).
Reconstituted p14-liposomes mediate liposome-cell lipid mixing at the plasma membrane Lipid mixing between p14-liposomes and cell membranes was assessed using a fluorescence resonance energy transfer assay (Struck et al, 1981) . Flow cytometry, rather than fluorimetry, was used to quantify increased cell-associated NBD fluorescence, indicative of transfer of the fluorescent lipids from liposomes to cell membranes. Flow cytometry provided a clearer indication of the range of fusion events (e.g. cells that have fused to multiple liposomes fluoresce more intensely and can be distinguished from cells that have fused to fewer liposomes), and allowed a clear distinction between fluorescent cells and background fluorescence due to residual liposomes adhered to cells.
The fluorescence intensity of cells incubated with p14-liposomes at 371C was compared to control samples representing p14-liposomes incubated at 41C (to prevent fusion) or liposomes lacking p14 incubated at 371C. Time-course analysis revealed a progressive increase in cellular fluorescence when p14-liposomes were incubated with target cells at 371C (Figure 3 ). Within 5-10 min after the shift to 371C, fluorescence intensity increased, as indicated by the rightward shift of the histogram, and continued to increase to maximal levels by 30-40 min. As indicated by the distribution of the histogram ( Figure 3A) , cell fluorescence intensity varied over two orders of magnitude, suggesting a wide variation in the number of fusion events per target cell. A graphical representation of the time points ( Figure 3B ), plotting the percent of cells in the target population with fluorescence intensities above background (t ¼ 0 intensity), indicated that lipid mixing reached maximal levels of B35-40% of the cells fluorescing above background. Using quantitative video microscopy, a similar situation was observed with fusion of HA-expressing cells to target red blood cells, where 25-30% of cells undergo full lipid mixing, with 70-80% of cells showing any level of lipid mixing . Increased cell fluorescence over time was not observed when LUVs lacking p14 (i.e. standard liposomes) were incubated with cells at 371C or when cells treated with p14-liposomes were incubated at 41C ( Figure 3B ), suggesting that purified p14 mediates lipid mixing and, by inference, the hemifusion phase of membrane fusion.
The increase in fluorescence over time observed with p14-liposomes could have resulted from increased p14-liposome adherence to target cells, followed by 'spontaneous' lipid transfer or endocytic disruption of the adhered liposomes. Analysis by atomic force microscopy revealed that Figure 3) . Cellbinding analysis also indicated that p14-liposomes adhere more strongly to target cells ( Figure 4A ). To exclude that this increased adherence was responsible for the observed difference in lipid mixing between p14-liposomes and standard liposomes, the dose of input liposomes was adjusted to yield equivalent numbers of liposomes adhered to cells. Under such conditions, standard liposomes exhibited no increase in fluorescence while p14-liposomes underwent a time-dependent increase in lipid mixing ( Figure 4B ), suggesting that the fluorescence increase observed in the lipid-mixing assay was specifically due to p14-mediated lipid mixing. Additional support for this conclusion was obtained by demonstrating that lysophosphatidylcholine (LPC), a monoacylated fatty acid known to inhibit membrane fusion (Chernomordik and Kozlov, 2003) , effectively inhibited lipid mixing between p14-liposomes and target cells in a dose-dependent manner (Supplementary Figure 4A) . Furthermore, endocytosis inhibitors reduced p14-induced lipid mixing by only 20% (Supplementary Figure 4B) , suggesting that endocytic entry pathways make only a minor contribution to the observed lipid-mixing. We conclude that p14 induces liposome-cell lipid mixing, indicative of the hemifusion phase of membrane fusion, and that membrane fusion occurs primarily at the plasma membrane, independent of cellular endocytic pathways.
Reconstituted p14-liposomes mediate content mixing
The ability of p14 to mediate pore formation was assessed using the aqueous fluor calcein to monitor delivery of liposome contents to the cytosol of target cells. As with the lipid-mixing assay, cells treated with calcein-containing p14-liposomes at 371C showed increased fluorescence over time, reaching maximal levels by 20 min that corresponded to B25% of the target cell population ( Figure 5A ). There was no increase in cellular fluorescence when cells were incubated at 371C with standard liposomes or with p14-liposomes incubated at 41C. Addition of similar levels of soluble calcein to cell monolayers resulted in no increased cell fluorescence (data not shown), implying that the cell fluorescence observed with calcein-containing p14-liposomes was not due to leakage of calcein out of the liposomes and into cells. Unlike the rapid onset of lipid mixing in o5 min, the intracellular delivery of calcein was not detected until after 10 min ( Figure 5A ). Whether this apparent lag simply reflects a decreased sensitivity of the content-mixing assay (i.e. the extent of calcein that must be delivered to cells before increased cell fluorescence is detectable) or something more interesting, such as the uncoupling of the lipid mixing and pore formation phases of the p14 fusion reaction, is unclear.
Repeating these assays with Vero epithelial cells indicated levels of lipid mixing and content mixing comparable to the results obtained with QM5 fibroblasts ( Figure 5B ). Using fluorescence microscopy, cellular fluorescence was observed for both the aqueous and lipidic fluors when Vero cells were incubated with p14-liposomes at 371C, but not when cells p14 is both necessary and sufficient for membrane fusion Liposome-liposome fusion assays were conducted to exclude the possibility that p14 might de dependent on formation of a trans-acting complex with a protein cofactor present in the target cell membrane. Initial experiments using our neutral liposomes did not detect p14-induced lipid mixing (data not shown). While p14-liposomes adhered to target cells (Figure 4) , we suspected that the same might not be true for p14-liposome adherence to artificial phospholipid bilayers, and that the lack of liposome-liposome fusion was due to the absence of sufficiently close liposome-liposome interactions. Therefore, p14 was reconstituted into the anionic liposome formulation (POPC (1-palmitoyl-2-oleoylphosphatidylcholine):DOPS (dioleoyl-phosphatidylserine) at 85:15 mol%) widely used to assess SNARE-mediated liposome fusion (Weber et al, 1998; Parlati et al, 1999; McNew et al, 2000; Chen et al, 2004) , and liposome-liposome interactions were promoted using divalent cations. In the absence of divalent cations, p14-induced lipid mixing barely exceeded the low level of spontaneous lipid mixing ( Figure 7A and B, curve c). The addition of divalent cations resulted in a dosedependent increase in lipid mixing for p14-liposomes, but had little to no effect on lipid mixing in the absence of p14 ( Figure 7A and B, curves a and b). This situation applied to both Ca 2 þ and Mg 2 þ , with Ca 2 þ exerting a more pronounced effect ( Figure 7C ).
Under optimal conditions for p14-induced lipid mixing, there was a sharp increase in NBD fluorescence in the first few minutes, which leveled off by 5-7 min at B15-20% of the theoretical maximum lipid mixing followed by a slow progressive increase in fluorescence from 10 to 30 min that paralleled the low rate of spontaneous lipid mixing observed between liposomes lacking p14 ( Figure 7A ). As with liposome-cell fusion, additional studies indicated that p14 need only be present in the donor membrane to effect lipid mixing between liposomes ( Figure 7D) . A modest increase in fusion activity was noted when p14 was present in both membranes; however, this effect was most likely the result of the 25% increase in the total amount of p14 in the system (i.e. a 4:1 ratio of donor:target membranes) rather than the need for p14 in both membranes, as suggested by the ability of p14-transfected cells to fuse to nontransfected cells (Supplementary Figure 1) . The ability of p14 to induce liposome-liposome fusion suggests that the p14 FAST protein is both necessary and sufficient to induce the lipid rearrangements required for merger of two lipid bilayers, making p14 the least complex protein-based membrane fusion machine described to date.
Intracellular delivery of a proapoptotic peptide by fusogenic p14-liposomes
To further examine the range of conditions under which p14 can function, p14 was formulated into cationic multilamellar vesicles (DOPC (1,2-dioleoyl-sn-glycerol-3 phosphatidylcholine): DOPE (1,2-dioleoyl-sn-glycerol-3 phosphatidylethanolamine): cholesterol:DC-cholesterol, molar ratios of 60:30:8:2, respectively), and assessed for its ability to mediate intracellular delivery of a proapoptotic peptide, lactoferricin (Lfcin). The Lfcin peptide is related to penetratins and defensins, and penetrates cell membranes to trigger the mitochondrialinduced apoptotic pathway (Vogel et al, 2002; Mader et al, 2005) . Soluble Lfcin induced an apoptotic response in Jurkat cells resulting in B80% cell death (Figure 8 ). Treatment of Jurkat cells with liposome-encapsulated Lfcin, using liposomes lacking p14, resulted in low levels of cell death (B5-10%) that were comparable to spontaneous apoptosis in these cells, indicating that the cationic Lfcin peptide remained entrapped within the cationic liposomes, and that such nonfusogenic liposomes are incapable of efficient intracellular cargo delivery. In contrast, identical liposome formulations containing p14 resulted in B80% cell death. The supernatant obtained following incubation of Lfcin-containing p14-liposomes or normal liposomes in cell culture medium for 24 h induced limited cell killing (Figure 8 ), indicating that p14 did not induce detectable leakage of the Lfcin from the liposomes. Although we cannot exclude the possibility that p14-liposomes may become leaky when interacting with cells, the results from the calcein studies ( Figure 5 ) indicate that p14 mediates intracellular content delivery independent of liposome leakage. Therefore, based on several lines of evidence, we conclude that p14 can mediate liposome fusion to a diversity of cell types, resulting in intracellular delivery of different aqueous cargoes in a manner that is relatively tolerant to wide variations in the donor membrane lipid composition.
Discussion
The exceptional structural features of the FAST protein family raised the question of whether these proteins function through indirect means to effect cell-cell membrane fusion, possibly by activating or modulating cellular fusion factors. We now show that purified p14 reconstituted into an artificial lipid bilayer mediates membrane fusion independent of any cis-or trans-acting protein cofactors. These results were confirmed using liposome-liposome and liposome-cell fusion assays, with both adherent and nonadherent cell lines, using different liposome cargoes (a fluorescent aqueous probe and a proapoptotic peptide), and in the presence of different lipid formulations (neutral, cationic, or anionic). The p14 FAST protein, therefore, is a promiscuous fusogen that functions to mediate complete membrane fusion. We also conclude that p14 is both necessary and sufficient to mediate membrane fusion, making the FAST proteins the least complex protein-mediated membrane fusion machines currently known. The reconstitution of fusogenic p14-liposomes has important implications on proposed models of FAST protein-mediated membrane fusion and on the available approaches to investigate the mechanism of FAST protein function.
The protein:lipid molar ratio of p14-liposomes (B1:300) corresponds to 6-7 Â10 3 p14 molecules per 400 nm LUV and surface densities of 1.2-1.4 Â 10 4 p14 molecules/mm 2 (see Supplementary data). These p14 densities are similar to those reported for influenza HA monomers on the surface of transfected cells or in virions, and for v-SNAREs in reconstituted liposomes or synaptic vesicles, which range from 0.3 to 9 Â10 4 protein molecules/mm 2 (Jahn and Sudhof, 1994; Danieli et al, 1996; Markovic et al, 2001; Chen et al, 2004) , and are approximately five-fold less than the densities of synaptic SNAREs in reconstituted liposomes (6 Â10 4 ) (Weber et al, 1998) . Consequently, approximately the same membrane density of p14 proteins is required to induce membrane fusion as reported for other, more complex membrane fusion complexes. The possibility of p14 clustering in the liposome membrane precludes speculation on the actual number of p14 molecules required at a given fusion site.
Kinetic analysis indicated that p14-liposomes initiated liposome-cell lipid mixing within 5 min following the shift to the fusion-permissive temperature of 371C, reaching maximal levels by 20-30 min with a half-time of B10 min. While lipid mixing between influenza HA-or HIV env-expressing cells and target cell membranes exhibits faster kinetics, going to completion in 3-5 min (Danieli et al, 1996 ; Markosyan 2003; Mittal et al, 2003) , other enveloped virus fusion proteins, either expressed in transfected cells or present in virus particles or reconstituted lipid vesicles, follow similar kinetics as p14-liposomes (Eidelman et al, 1984; Blumenthal et al, 1987; Earp et al, 2003; Kolokoltsov and Davey, 2004) . In the case of p14-mediated liposome-liposome fusion, the kinetics and extent of lipid mixing closely mirror results reported for SNARE-mediated membrane fusion. For example, neuronal SNAREs mediate liposome liposome lipid mixing with half-times of 4-10 min (Parlati et al, 1999; Melia et al, 2002) , while yeast SNAREs fuse liposomes with a halftime of 20-30 min, reaching B20% of the theoretical maximum by B60 min (Chen et al, 2004) . Although these are qualitative comparisons between different systems and different assays, based on membrane protein density and the kinetics of lipid mixing (both in liposome-cell and liposomeliposome fusion assays), the results suggest that the relative efficiency of the p14 membrane fusion machine may rival that of the more complex homomeric or heteromeric enveloped virus and cellular fusion machinery. The relative efficiency of p14 as a fusogen is a remarkable observation in view of the minimal size of the FAST protein family members. The simplicity of this fusion machine contrasts markedly with the complex homomeric or heteromeric membrane fusion machinery of the enveloped viruses or SNARE proteins. Unlike SNARE proteins that form transacting multimeric complexes to draw the donor and target membranes into close proximity (Weber et al, 1998) , results from liposome-liposome and/or cell-cell fusion assays indicate that this is not the case for the p14 (Supplementary Figure 1 and Figure 7D ) and p10 FAST proteins (Shmulevitz et al, 2004b) . While enveloped virus fusion proteins also function from only one of the two membranes, they do so using complex ectodomains that contrast markedly with the B20-44-residue ectodomains of the FAST proteins (Earp et al, 2005) .
For both the SNARE proteins and enveloped virus fusion proteins, lipid-mixing and content-mixing are tightly coupled and dependent on the coordinated, sequential refolding of the multimeric fusion complexes (Melikyan et al, 2000; Markosyan et al, 2003; Cohen and Melikyan, 2004) . These structural rearrangements serve to draw the apposing membranes together and/or provide the energy required for pore formation and expansion. Based on the small size of their ectodomains, it seems unlikely that the FAST proteins drive membrane fusion by undergoing such extensive structural remodeling. The physical stature of the FAST protein ectodomains is also incompatible with models based on triggered conformational release of a fusion peptide previously sequestered within a complex folded ectodomain. In fact, analysis of p10 degradation suggests that the fusion peptide may be solvent accessible (Shmulevitz et al, 2004a) , and there is no evidence to indicate that the FAST proteins undergo a transition from a fusion-incompetent precursor to a fusion-active form. It therefore seems that the FAST proteins must utilize some means other than triggered conformational changes in complex, multimeric structures to overcome the thermodynamic barriers that prevent spontaneous membrane fusion.
Based on available evidence, we currently favor a model whereby a combination of membrane-destabilizing modules, working from either side of the donor membrane, may function in concert to alter the water layer and lipid packing, leading to more disordered fusion intermediates and lowered energy requirements. Such a 'lipid-mixer' model was recently proposed for influenza HA (Tamm, 2003; Tamm et al, 2003) , and is more in-line with the structural features of the FAST proteins. The p14 protein has at its disposal several membrane-interaction motifs that may serve to effect the various steps in the membrane fusion reaction, including a fusion peptide motif and N-terminal myristate moiety in its small ectodomain, the transmembrane domain, and a membraneproximal polybasic region . Discerning the role of these p14 motifs in what may be a novel mechanism of protein-mediated membrane fusion can now be pursued using the fusogenic p14-liposome system.
Materials and methods
Plasmids and cells
The full-length cDNA clone of the RRV p14 gene in pcDNA3 was previously described . A recombinant baculovirus was created for p14 expression (see Supplementary data for details). QM5 fibroblasts and Vero cells were grown and maintained as previously described . Human T-cell leukemia (Jurkat) cells were maintained in RPMI 1640 medium (Sigma) supplemented with 5% fetal bovine serum (FBS) and penicillin/streptomycin. SF21 Spodoptera frugiperda cells were grown and maintained in SF900II insect cell culture medium (Invitrogen) supplemented with 3% FBS using suspension cultures.
Purification of p14
Purified p14 was obtained from recombinant baculovirus-infected insect cells following detergent lysis, binding to Talon metal affinity resin, and HiTrap SP HP ion exchange chromatography in the presence of 1.6% OG (see Supplementary data for details). Analysis by mass spectroscopy confirmed that the purified protein (1.5-2 mg/ml) corresponded to p14. The purity of the protein was 495%, as estimated by SDS-PAGE and densitometry analysis of silver-stained gels, and the protein was myristoylated (Supplementary Figure 2 ).
Preparation of proteoliposomes
All lipids were from Avanti Polar Lipids. Dried lipid films (DOPC:DOPE:cholesterol:sphingomyelin at molar ratios of 40:20:20:20) were resuspended in HEPES buffered salt solution (HBS; 10 mM HEPES, pH 7.4, 150 mM NaCl) and extruded through a 400 nm polycarbonate filter using a small-volume extrusion apparatus (Avestin, Ottawa, Canada). The rest of the procedure was conducted at 41C, unless otherwise noted. A 0.5 ml detergentsaturated liposome suspension (13.2 mM lipid and 1% (w/v) OG) was mixed with an equal volume of purified p14 (0.6 mg/ml in 1% (w/v) OG) and rocked for 60 min. The concentration of OG was decreased in 0.1% increments to a final concentration of 0.4% (w/v) by sequential dilution at 41C with HBS (30 min intervals), followed by extensive dialysis against HBS containing Bio-Beads SM-2 Adsorbent (BioRad) to remove residual detergent. For comparison of protein reconstitution methods, proteoliposomes were made at room temperature (221C) using the above protocol, the dilution steps were omitted before dialysis, or both the temperature was changed and the dilution omitted. A 500 ml aliquot of the resulting proteoliposome mixture was mixed with an equal volume of 60% sucrose (w/w) in HBS, overlaid with 2 ml of 20% sucrose and 1 ml of HBS, and centrifuged at 165 000 g for 1 h at 41C. Fractions (500 ml) were collected from the 0-20 and 20-30% sucrose interfaces, and from the 30% sucrose fraction, and analyzed by SDS-PAGE and silver staining.
Immunofluorescent staining of p14-liposomes
The topology of p14 in the membrane of proteoliposomes was determined by immunofluorescent staining using 1/400 dilutions of either polyclonal rabbit antiserum raised against a synthetic peptide representing residues 5-31 of the p14 N-terminal ectodomain (New England Peptide) or a polyclonal antibody that recognized the C-terminal enterokinase tag (Bethyl Laboratories), and Alexa 488-conjugated secondary goat anti-rabbit antibody (1/200 dilution). The liposomes were washed extensively with HBS and fluorescence was quantified by flow cytometry (FACScalibur, Beckton-Dickinson). As controls, liposomes lacking p14 were similarly stained, or p14-proteoliposomes were stained with only the secondary antibody or with normal rabbit serum. Western blotting indicated that both antisera recognized the p14 construct (Supplementary Figure  5) with slightly different affinities (a-ectodomain4a-enterokinase).
Binding and fusion assays
Cell monolayers in 12-well plates were washed with Hanks' buffered salt solution (HBSS) and chilled on ice. Suspensions (500 ml) of p14-proteoliposomes or standard liposomes were added to the target cell monolayers (0.33-1.32 mM lipid) and incubated on ice for 1 h to allow liposome adherence to cells. Unbound liposomes were removed by washing, and the monolayers were analyzed for liposome binding, lipid mixing, and content mixing using the following protocols.
Binding assay. Fluorescent liposomes were prepared using DOPC: DOPE:cholesterol:sphingomyelin:NBD-DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) at molar ratios of 40:19:20:20:1, respectively. Cells were washed with PBS, detached from the substratum using 10 mM EDTA, and bound liposomes quantified by flow cytometry using excitation and emission wavelengths of 460 and 534 nm, respectively.
Lipid-mixing assay. Lipid mixing between liposome and target cell membranes was quantified using a fluorescence resonance energy transfer assay (Struck et al, 1981) . Fluorescent liposomes were prepared using DOPC:DOPE:cholesterol: sphingomyelin:NBD-DOPE:rhodamine-DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)) at molar ratios of 40:17:20:20:1:2, respectively. After the 1 h binding incubation, cell temperature was either kept at 41C or rapidly changed to 371C using prewarmed HBSS, and cells were incubated at the same temperatures for the indicated durations. At the end of each time point, cells were rapidly cooled to 41C and detached from the substratum by incubation on ice for 15 min with 0.1 mg/ml proteinase K (QiaGen). The extent of lipid mixing was quantified by flow cytometry (see below).
Pore formation assay. Liposomes were prepared in the presence of 20 mM calcein. Analysis of the various liposome preparations indicated no significant difference in the entrapment efficiency of calcein inside p14-liposomes versus standard liposomes (74%). The calcein-containing liposomes were used to monitor intracellular delivery, as described in the lipid-mixing protocol.
Flow cytometry
Both lipid mixing and content mixing were quantified by flow cytometry (FACScalibur, Beckton-Dickinson) as a function of increasing NBD fluorescence or calcein fluorescence, respectively, measured in the FL1 channel. Flow cytometric measurements of fluorescent cells were conducted using a gate in the forward-side scatter plot that excluded free liposomes that were easily distinguishable from cells. The gating parameters were determined from the forward-side scatter plots of untreated cells and free liposomes. A total of 10 000 events within the cell gate were counted. The percentage of cells with increased fluorescence was calculated using Overton subtractions (Overton, 1988) of the experimental sample against the control sample (e.g. fluorescence at t ¼ 40 min versus fluorescence at t ¼ 0).
Fluorescence microscopy of lipid mixing and pore formation
Vero cell monolayers were treated with p14-proteoliposomes or normal liposomes, labeled with rhodamine-DOPE and calcein, as described above. After incubation for 20 min to allow lipid mixing and content mixing, the proteinase K-treated cells were resuspended in 1 ml of FBS, pelleted at 100 g for 5 min at 41C, and resuspended in 200 ml of Earle's medium containing 10% FBS. Suspended cells were centrifuged onto glass slides using a cytocentrifuge, fixed with 2% (w/v) paraformaldehyde, and mounted using fluorescent mounting media (Dako). Cells were visualized and photographed using a Zeiss LSM510 scanning argon laser confocal microscope and the Â 100 objective. Serial sections (0.5 mm) were taken at both the rhodamine and calcein wavelengths.
Liposome-liposome fusion assays
Lipid mixing between liposomes was assessed using the method of Weber et al (1998) . POPC and DOPS were resuspended in chloroform/methanol (2:1) at an 85:15 molar ratio, and dried under negative pressure. The lipid film was rehydrated to obtain a 20 mM lipid concentration in HBS, and extruded through 400 nm polycarbonate filters. Fluorescent target liposomes lacking p14 were similarly prepared, using an 82:15:2:1 lipid molar ratio of POPC:DOPS:rhodamine-DPPE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)):NBD-DPPE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)), respectively. The purified p14 protein was incorporated into nonfluorescent, detergent-saturated (0.9% OG) liposomes following the standard detergent dilution approach described above. The p14-liposomes were mixed with fluorescent liposomes (4:1 ratio, respectively) and incubated on ice for 5 min. The liposome mixture was then added to a cuvette containing prewarmed HBS and 10 mM MgCl 2 or CaCl 2 as indicated, and incubated at 371C with stirring. Increased NBD fluorescence was monitored for 120 min using a Varian spectrofluorimeter with a slit width of 20 nm, using excitation and emission wavelengths of 460 or 535 nm, respectively. Maximum lipid mixing was estimated from liposomes solubilized in the presence of 1% Triton X-100. The lowest fluorescence intensity during the time course was set as minimum lipid mixing.
Lactoferricin peptide delivery
The 25-residue Lfcin-B peptide was entrapped inside cationic p14-liposomes (60:30:8:2 molar ratio of DOPC:DOPE:cholesterol: ,N 0 -dimethylaminoethane)-carbamoyl) cholesterol hydrochloride]) by 10 freeze-thaw cycles using liquid nitrogen and a 371C water bath. The resulting multilamellar liposomes were washed with HBS and resuspended in RPMI medium to give a final concentration of 33.3 mM lipid. The concentration of entrapped Lfcin, as determined by HPLC analysis of the difference between the starting peptide concentration and the concentration of the residual nonentrapped peptide, was 1.13-1.23 mg/ml and differed by o8% between liposomes and p14-proteoliposomes. Intracellular delivery of Lfcin-B was assessed by DNA degradation analysis of [ 3 H]thymidine-labeled Jurkat cells, as previously described (Matzinger, 1991) .
Supplementary data
Supplementary data are available at The EMBO Journal Online.
